Guillain Barré syndrome and Coronavirus infection / Síndrome de Guillain Barré e infecção por Coronavírus
DOI:
https://doi.org/10.34119/bjhrv5n1-152Keywords:
Guillain Barré Syndrome, COVID-19, neurologic infection COVID-19, SARS-CoV-2.Abstract
The coronavirus (COVID-19) pandemic is a major problem of public health worldwide since 2020. The virus that first started causing pneumonia in Wuhan, China, has spread throughout all six continents and is now also known for causing other health issues, including neurological infection. In the last months, there were many case reports of Guillain-Barré Syndrome (GBS) in patients with SARS-CoV-2 infection, raising concerns over a possible association. The coronavirus infiltrated in neuronal tissue is able to modify the pathophysiology of GBS, that is a polyneuropathy and also an autoimmune disease, commonly triggered by infections of the human body. Acute inflammatory demyelinating polyneuropathy (AIDP) is one of the most common types of demyelinating polyneuropathy, causing loss of the myelin sheath, what makes electrical messages cannot travel between the brain and the periphery of the body. This association must be early diagnosed so that the physician can manage it to avoid respiratory depression and other consequences of the condition.
References
Romero-Sánchezr, CM et al (2020) . Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. American Academy of Neurology. https://doi.org/10.1212/WNL.0000000000009937
Paliwal VK, Garg RK, Gupta A, Tejan N (2020) Neuromuscular presentations in patients with COVID-19. Neurol Sci. doi:10.1007/s10072-020-04708-8
Zito A, Alfonsi E, Franciotta D et al (2020) COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature. Frontiers in Neurology. doi: 10.3389/fneur.2020.00909
Unicini A, Vallat JM, Jacobs BC (2020) Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry. DOI 10.1136 / jnnp-2020-324491.
Parry G, Steinberg J (2007) Guillain-Barré Syndrome. New York, New York
Sriwastava S, Kataria S, Tandon M et alt (2021). Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series. Journal of the Neurological Sciences. doi: 10.1016/j.jns.2020.117263
Malta J, Ramalho W (2020). Aumento das internações por síndrome de Guillain-Barré no Brasil: estudo ecológico. Epidemiol. Serv. Saúde. http://dx.doi.org/10.5123/s1679-49742020000400020.
Simões J, Bagatini M (2020). Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome. Journal of Neuroimmune Pharmacology. DOI 10.1007 / s11481-020-09980-1.
Yachou Y, Idrissi A, Belapasov V, Benali S (2020). Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurological Sciences. DOI 10.1007 / s10072-020-04575-3.
Khatoon F, Prasad K, Kumar V (2021). Neurological manifestations of COVID-19: available evidences and a new paradigm. Journal of NeuroVirology. DOI 10.1007 / s13365-020-00895-4.
Kajumba MM, Kolls BJ, Koltai DC et al (2020). COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications. SN comprehensive clinical medicine. doi:10.1007/s42399-020-00646-w
Hasan, I., Saif-Ur-Rahman, K. M., Hayat, S et al (2020). Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis. Journal of the peripheral nervous system : JPNS, 25(4), 335–343. https://doi.org/10.1111/jns.12419
Caress, J. B., Castoro, R. J., Simmons, Z. et al (2020). COVID-19-associated Guillain-Barré syndrome: The early pandemic experience. Muscle & nerve, 62(4), 485–491. https://doi.org/10.1002/mus.27024
Abu-Rumeileh, S., Abdelhak, A., Foschi, M. et al (2021). Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. Journal of neurology, 268(4), 1133–1170. https://doi.org/10.1007/s00415-020-10124-x
Fragiel, M., Miró, Ò., Llorens, P et al (2021). Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19. Annals of neurology, 89(3), 598–603. https://doi.org/10.1002/ana.25987
Ghannam, M., Alshaer, Q., Al-Chalabi, M et al (2020). Neurological involvement of coronavirus disease 2019: a systematic review. Journal of neurology, 267(11), 3135–3153. https://doi.org/10.1007/s00415-020-09990-2
Hussain, F. S., Eldeeb, M. A., Blackmore, D., & Siddiqi, Z. A. (2020). Guillain Barré syndrome and COVID-19: Possible role of the cytokine storm. Autoimmunity reviews, 19(12), 102681. https://doi.org/10.1016/j.autrev.2020.102681
Dalakas M. C. (2020). Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing. Neurology(R) neuroimmunology & neuroinflammation, 7(5), e781. https://doi.org/10.1212/NXI.0000000000000781
Masuccio, F. G., Barra, M., Claudio, G., & Claudio, S. (2021). A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection. Journal of neurology, 268(7), 2327–2330. https://doi.org/10.1007/s00415-020-10219-5
Maideniuc, C., & Memon, A. B. (2021). RETRACTED ARTICLE: Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient. Journal of neurology, 268(2), 739. https://doi.org/10.1007/s00415-020-10145-6
Cappello F. (2020). COVID-19 and molecular mimicry: The Columbus' egg?. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 77, 246. https://doi.org/10.1016/j.jocn.2020.05.015
Boostani, R., Talab, F. R., Meibodi, N. T., & Zemorshidi, F. (2020). COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report. Journal of neuroimmunology, 350, 577434. Advance online publication. https://doi.org/10.1016/j.jneuroim.2020.577434
Morsy S. (2020). NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome. Medical hypotheses, 145, 110342. https://doi.org/10.1016/j.mehy.2020.110342
Faqihi, F., Alharthy, A., Memish, Z. A., Kutsogiannis, D. J., Brindley, P. G., & Karakitsos, D. (2020). Peripheral neuropathy in severe COVID-19 resolved with therapeutic plasma exchange. Clinical case reports, 8(12), 3234–3239. Advance online publication. https://doi.org/10.1002/ccr3.3397.
Abolmaali M, Heidari M, Zeinali M et al (2021). Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 83, 119–122. https://doi.org/10.1016/j.jocn.2020.11.013
